 |
|
 |
 |
|
Fig. 2A.
CEA in
moderately
differentiated adenocarcinoma of colon. Strong
membraneous and cytoplasmic staining with mAb Col-1. |
Fig. 2B.
CEA in poorly differentiated adenocarcinoma of colon. Strong
membraneous and cytoplasmic staining with mAb Col-1. |
 |
 |
|
Fig. 2C. CEA in breast ductal
carcinoma. Note the heterogenous staining, often distinctly
membraneous. mAb Col-1. |
Fig. 2D.
CEA in medullary thyroid
carcinoma. mAb Col-1. |
Biliary glycoptotein-1
in
neoplasms
|
 |
Fig. 2E.
Hepatocellular carcinoma with strong membraneous staining of BGP in
bile canaliculi. pAb CEA A0115 (DakoCytomation)
cross reaction. Note that this should not be termed a CEA staining. |
